POLTECHRBC 13.40MG/VIAL POWDER FOR INJECTION

Država: Cipar

Jezik: grčki

Izvor: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Aktivni sastojci:

SODIUM PYROPHOSPHATE DECAHYDRATE

Dostupno od:

NATIONAL CENTRE FOR NUCLEAR RESEARCH (0000009483) ANDRZEJA SOLTANA STR. 7, OTWOCK, 05-400

ATC koda:

V09GA06

INN (International ime):

TECHNETIUM (99MTC) STANNOUS AGENT LABELLED CELLS

Doziranje:

13.40MG/VIAL

Farmaceutski oblik:

POWDER FOR INJECTION

Sastav:

SODIUM PYROPHOSPHATE DECAHYDRATE (0013472361) 13,4MG

Administracija rute:

INTRAVENOUS USE

Tip recepta:

Ειδική άδεια άρθρο 126A

Područje terapije:

TECHNETIUM (99mTc) STANNOUS AGENT LABELLED CELLS

Proizvod sažetak:

Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 6 VIALS () 6 VIAL - Εγκεκριμένο - Με Ιατρική Συνταγή

Uputa o lijeku

1
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
POLTECHRBC, 13.40 MG, LYOPHILISATE FOR SOLUTION FOR INJECTION
_Stanni pyrophosphatis et technetii (_
_99m_
_Tc) solutio iniectabilis _
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your referring doctor or your
nuclear medicine doctor
who will supervise the procedure.
-
If you get any side effects, talk to your nuclear medicine doctor.
This includes any possible side
effects not listed in this leaflet.
WHAT IS IN THIS LEAFLET
:
1.
What PoltechRBC is and what it is used for.
2.
What you need to know before PoltechRBC is used.
3.
How PoltechRBC is used.
4.
Possible side effects.
5.
How PoltechRBC is stored.
6.
Contents of the pack and other information.
1.WHAT
POLTECHRBC
IS
AND
WHAT
IT
IS
USED
FOR
This medicine is a radiopharmaceutical product for diagnostic use
only.
PoltechRBC is used for:
Blood pool scintigraphy with labelled red blood cells, which is useful
for:
•
scintigraphy to assess:
- cardiac ventricles ejection fraction,
- regional and global cardiac walls motion.
•
imaging of perfusion of organs and vascular malformations,
•
diagnosis and localisation of gastrointestinal bleeding.
Assessment of blood volume.
Spleen scintigraphy.
The use of PoltechRBC does involve exposure to small amounts of
radioactivity. Your doctor has
considered that the clinical benefit that you will obtain from the
procedure with the
radiopharmaceutical outweights the risk due to ionising radiation.
2.WHAT YOU NEED TO KNOW BEFORE POLTECHRBC IS USED
POLTECHRBC MUST NOT BE USED
PoltechRBC must not be used if you are allergic (hypersensitive) to
the active substance or any of the
other ingredients of this medicine (listed in section 6).
WARNINGS AND PRECAUTIONS
Inform the nuclear medicine doctor who is supervising the examination
in the following cases:
- if you are pregnant or believe you may be pregnant,
- if you are breast-feeding,
- if you are under 18 years old.